Lalit Bora, Obstetric and Gynaecological Societies of India, India
Polycystic ovarian disease is one of the most common endocrine disorders affecting women of reproductive age and adolescents. It doesn’t spare even perimenopausal women. PCOS is the most common cause of anovulatory infertility in women. The global prevalence of PCOS varie [....]
» Read More
Objectives: Inflammation is a hallmark of HPV-mediated cervical cancer; Matrix metalloproteinase [MMP]-2 and tissue inhibitor of metalloproteinase [TIMP]-2 are emerging as pivotal players in inflammation and carcinogenesis. My study aimed to evaluate the role of MMP-2 (-735C>T [....]
» Read More
INTRODUCTION: Cervical cancer remains a global health challenge, particularly in resource-limited settings. This study assesses the effectiveness of point-of-care Truenat HPV DNA screening for cervical cancer, aiming for same-day reporting.
AIM: To evaluate the diagnostic perfor [....]
» Read More
Title : Inositol in treating sub fertile women and Adolescents with PCOS
Lalit Bora, Obstetric and Gynaecological Societies of India, India
Polycystic ovarian disease is one of the most common endocrine disorders affecting women of reproductive age and adolescents. It doesn’t spare even perimenopausal women. PCOS is the most common cause of anovulatory infertility in women. The global prevalence of PCOS varie [....] » Read More
Title : Impact of matrix metalloproteinase [MMP]-2 (2735C>T) and tissue inhibitor of metalloproteinase [TIMP]-2 (2418G>C) gene polymorphisms with human papillomavirus-mediated cervical cancer: Emerging trends in Gynecologic Oncology
Saumya Pandey, Indira-IVF Hospital, India
Objectives: Inflammation is a hallmark of HPV-mediated cervical cancer; Matrix metalloproteinase [MMP]-2 and tissue inhibitor of metalloproteinase [TIMP]-2 are emerging as pivotal players in inflammation and carcinogenesis. My study aimed to evaluate the role of MMP-2 (-735C>T [....] » Read More
Title : Gynecology Conferences
Shaina, Dayanand Medical College, India
INTRODUCTION: Cervical cancer remains a global health challenge, particularly in resource-limited settings. This study assesses the effectiveness of point-of-care Truenat HPV DNA screening for cervical cancer, aiming for same-day reporting. AIM: To evaluate the diagnostic perfor [....] » Read More